22.05.2017 Views

Review of Pharmacology - 9E (2015)

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chemotherapy B: Antimicrobials for Specific Conditions<br />

608<br />

<strong>Review</strong> <strong>of</strong> <strong>Pharmacology</strong><br />

anti-hiv drugs<br />

103. All <strong>of</strong> the following are common adverse effects <strong>of</strong><br />

HAART therapy except:<br />

(a) Steatosis<br />

(b) Lipodytrophy<br />

(c) Optic neuritis<br />

(d) Increased cholesterol<br />

104. A person is being treated for Human Immunodeficiency<br />

Virus-1. He developed hypertriglyceridemia and<br />

hypercholesterolem0ia. Most likely drug implicated for<br />

these adverse effects is: (AI 2012)<br />

(a) Ritonavir<br />

(b) Raltegravir<br />

(c) Didanosine<br />

(d) Efavirenz<br />

105. Efavirenz is used for treatment <strong>of</strong> HIV infections. It acts<br />

(a) As protease inhibitor (AIIMS Nov. 2011)<br />

(b) As reverse transcriptase inhibitor<br />

(c) As integrase inhibitor<br />

(d) By inhibiting the HIV entry into the cell<br />

106. Which <strong>of</strong> the following drugs is used to prevent HIV<br />

transmission from an HIV positive pregnant mother to<br />

child? (AIIMS Nov. 2011)<br />

(a) Lamivudine<br />

(b) Stavudine<br />

(c) Nevirapine<br />

(d) Didanosine<br />

107. Which is the integrase inhibitor used in treatment <strong>of</strong><br />

HIV? (AI 2011)<br />

(a) Raltegravir<br />

(b) Indinavir<br />

(c) Lopinavir<br />

(d) Fosamprenavir<br />

108. All <strong>of</strong> the following cause inhibition <strong>of</strong> CYP3A except:<br />

(a) Saquinavir (AIIMS May 2010)<br />

(b) Ritonavir<br />

(c) Itraconazole<br />

(d) Erythromycin<br />

109. Which <strong>of</strong> the following drug is a reverse transcriptase<br />

inhibitor? (DPG - 2011)<br />

(a) Indinavir<br />

(b) Ritonavir<br />

(c) Nelfinavir<br />

(d) Abacavir<br />

110. Maximum risk <strong>of</strong> pancreatitis is present with:<br />

(a) Didanosine (AI 2010)<br />

(b) Lamivudine<br />

(c) Zidovudine<br />

(d) Abacavir<br />

111. The basis <strong>of</strong> combining ritonavir with lopinavir:<br />

(a) Pharmaceutical compatibility (DPG 2009)<br />

(b) C4P3A4 inhibition by ritonavir<br />

(c) Long elimination half life <strong>of</strong> ritonavir<br />

(d) Ability to counteract side-effects <strong>of</strong> lopinavir<br />

112. Nevirapine is: (AI 2007, 2006, 2005)<br />

(a) Non-nucleoside reverse transcriptase inhibitor<br />

(NNRTI) (AIIMS May 2004, RJ 2008)<br />

(b) Nucleoside reverse transcriptase inhibitor (NRTI)<br />

(c) Protease inhibitor<br />

(d) Fusion inhibitor<br />

113. Drug causing maximum peripheral neuropathy is:<br />

(a) Zidovudine (AI 2007)<br />

(b) Lamivudine<br />

(c) Stavudine<br />

(d) Didanosine<br />

114. All <strong>of</strong> the following drugs are protease inhibitors<br />

EXCEPT: (AI 2006)<br />

(a) Nelfinavir<br />

(b) Saquinavir<br />

(c) Abacavir<br />

(d) Ritonavir<br />

115. Which <strong>of</strong> the following anti-retroviral drugs does not<br />

cause peripheral neuropathy? (AI 2000)<br />

(a) Lamivudine<br />

(b) Stavudine<br />

(c) Didanosine<br />

(d) Zalcitabine<br />

116. True about protease inhibitors are all except:<br />

(AIIMS Nov., 2007)<br />

(a) Acts as a substrate for P-glycoprotein(P-gp) and<br />

action is mediated by mdr-1 gene<br />

(b) undergo hepatic oxidative metabolism<br />

(c) Protease inhibitors interfere with metabolism <strong>of</strong><br />

several drugs<br />

(d) Saquinavir causes maximum induction <strong>of</strong> CYP3A4<br />

117. Resistance to zidovudine develops due to:<br />

(AIIMS May, 2005)<br />

(a) Mutation at reverse transcriptase<br />

(b) Increased efflux <strong>of</strong> the drug from inside the cell<br />

(c) Increased metabolism <strong>of</strong> the drug<br />

(d) Decreased zidovudine 5 triphosphate formation<br />

118. Complications <strong>of</strong> zidovudine therapy are:<br />

(a) Nausea and vomiting (PGI June, 2006)<br />

(b) Anemia<br />

(c) Steatosis<br />

(d) Nephrotoxicity<br />

(e) Cardiotoxicity<br />

119. Nucleoside reverse transcriptase inhibitors are:<br />

(a) Zalcitabine (PGI June, 2004)<br />

(b) Delavirdine<br />

(c) Nevirapine<br />

(d) Stavudine<br />

(e) Ritonavir<br />

https://kat.cr/user/Blink99/

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!